glp-1 receptor agonist type 1 diabetes randomized trial New Developments in Pharmacological Treatment of Obesity and 2 Diabetes—Beyond and within Agonists GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
What did they find
As more patients started these therapies, more people also reported severe gastrointestinal symptoms, prompting closer scrutiny from clinicians, regulators, and plaintiffs attorneys
thus, transoral outlet reduction aims to reduce the size of the anastomosis via endoscopic suturing
Theres a big footnote for this trial that takes us back to the Bhaumik award and why there was such a long time before the realization the GLP-1 drugs could be useful for obesitypeople with diabetes on GLP-1 drugs didnt lose much weight
New generation antidepressants for depression in children and adolescents: a network meta-analysis
